Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Saliou

Showing results (71-80 of 144) with videos related to

Pageof 15
Sort By:
Bulletin De La Societe De Pathologie Exotique (1990)|January 1, 1991
[Immunogenicity and harmlessness in the newborn of a vaccine (GenHevac B) containing the antigens S and pre-S2]F Tron, J C Soulié, A Goudeau, et al.
Biologicals : Journal of the International Association of Biological Standardization|July 8, 2000
A TritonX-100-split virion influenza vaccine is safe and fulfills the committee for proprietary medicinal products (CPMP) recommendations for the European Community for Immunogenicity, in Children, Adults and the ElderlyB Lina, M A Fletcher, M Valette, et al.
Vaccine|January 1, 1995
Simultaneous injection of plasma-derived or recombinant hepatitis B vaccines with yellow fever and killed polio vaccinesP Coursaget, B Fritzell, C Blondeau, et al.
Bulletin of the World Health Organization|January 1, 1971
[Formation of fluorescent antibodies during human malaria caused by malaria therapy with Plasmodium vivax]J P Garin, P Ambroise-Thomas, T K Truong, et al.
Developments in Biological Standardization|January 1, 1978
[Controlled tests of anti-meningococcal polysaccharide A vaccine in the African Sahel area (Upper Volta and Mali) ]P Saliou, P Stoeckel, A Lafaye, et al.
Revue Du Rhumatisme Et Des Maladies Osteo-Articulaires|January 1, 1982
[Immunologic aspects of ankylosing spondylarthritis]P Saliou, A Thabaut, J L Durosoir, et al.
European Journal of Pediatrics|September 15, 1999
Safety and immunogenicity of Haemophilus influenzae type b-tetanus toxoid conjugate, presented in a dual-chamber syringe with diphtheria-tetanus-pertussis and inactivated poliomyelitis combination vaccineJ Langue, C Ethevenaux, A Champsaur, et al.
Vaccine|July 1, 1991
Comparative trial of administration of half (0.05 mg) and quarter (0.025 mg) dose of intradermal Pasteur BCG on 291 infants from birth to 1 year in French GuyanaL Teulieres, M A Diouf, P Chaud, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|August 22, 2001
[Evaluation of tolerance to endovesical BCG treatment in France: analysis of severe adverse effects notified in 3 years]H Debois, E Loupi, P Saliou, et al.
Medecine Tropicale : Revue Du Corps De Sante Colonial|May 16, 2008
[Proceedings of the Paris 2007 International Workshop "Ethics in health research in southern hemisphere countries"]M Ahouanto, S Barbe, J M Milleliri, et al.
Pageof 15

Showing results (71-80 of 144) with videos related to

Sort By:
Pageof 15
Bulletin De La Societe De Pathologie Exotique (1990)|January 1, 1991
[Immunogenicity and harmlessness in the newborn of a vaccine (GenHevac B) containing the antigens S and pre-S2]F Tron, J C Soulié, A Goudeau, et al.
Biologicals : Journal of the International Association of Biological Standardization|July 8, 2000
A TritonX-100-split virion influenza vaccine is safe and fulfills the committee for proprietary medicinal products (CPMP) recommendations for the European Community for Immunogenicity, in Children, Adults and the ElderlyB Lina, M A Fletcher, M Valette, et al.
Vaccine|January 1, 1995
Simultaneous injection of plasma-derived or recombinant hepatitis B vaccines with yellow fever and killed polio vaccinesP Coursaget, B Fritzell, C Blondeau, et al.
Bulletin of the World Health Organization|January 1, 1971
[Formation of fluorescent antibodies during human malaria caused by malaria therapy with Plasmodium vivax]J P Garin, P Ambroise-Thomas, T K Truong, et al.
Developments in Biological Standardization|January 1, 1978
[Controlled tests of anti-meningococcal polysaccharide A vaccine in the African Sahel area (Upper Volta and Mali) ]P Saliou, P Stoeckel, A Lafaye, et al.
Revue Du Rhumatisme Et Des Maladies Osteo-Articulaires|January 1, 1982
[Immunologic aspects of ankylosing spondylarthritis]P Saliou, A Thabaut, J L Durosoir, et al.
European Journal of Pediatrics|September 15, 1999
Safety and immunogenicity of Haemophilus influenzae type b-tetanus toxoid conjugate, presented in a dual-chamber syringe with diphtheria-tetanus-pertussis and inactivated poliomyelitis combination vaccineJ Langue, C Ethevenaux, A Champsaur, et al.
Vaccine|July 1, 1991
Comparative trial of administration of half (0.05 mg) and quarter (0.025 mg) dose of intradermal Pasteur BCG on 291 infants from birth to 1 year in French GuyanaL Teulieres, M A Diouf, P Chaud, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|August 22, 2001
[Evaluation of tolerance to endovesical BCG treatment in France: analysis of severe adverse effects notified in 3 years]H Debois, E Loupi, P Saliou, et al.
Medecine Tropicale : Revue Du Corps De Sante Colonial|May 16, 2008
[Proceedings of the Paris 2007 International Workshop "Ethics in health research in southern hemisphere countries"]M Ahouanto, S Barbe, J M Milleliri, et al.
Pageof 15